2017
DOI: 10.1021/acsmedchemlett.7b00044
|View full text |Cite
|
Sign up to set email alerts
|

Opioid Receptor Activity and Analgesic Potency of DPDPE Peptide Analogues Containing a Xylene Bridge

Abstract: d-Pen,d-Pen enkephalin (DPDPE) is one of the most selective synthetic peptide agonists targeting the δ-opioid receptor. Three cyclic analogues of DPDPE containing a xylene bridge in place of disulfide bond have been synthesized and fully characterized as opioid receptors agonists. The activity was investigated showing a good affinity of- for μ- and δ-receptors. biological assays revealed that is the most potent analogue with the ability to maintain high level of analgesia from 15 to 60 min following intracereb… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
22
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
7

Relationship

4
3

Authors

Journals

citations
Cited by 13 publications
(23 citation statements)
references
References 30 publications
1
22
0
Order By: Relevance
“…The same pattern was found for the blocking activity toward Cav2.2 when compared to ziconotide. [22][23][24][25] However, it is worth noting that the improvement of the antinociceptive effect recorded for compound 5a compared with that previously reported for compound 10 in the tail flick test, (Figure 4), may be either related to a higher potency to the Cav2.2 and/or to better tissue penetration and pharmacokinetic. Indeed, the calcium channel blocker activity of 5a is 200 times higher than that of compound 10.…”
Section: Please Do Not Adjust Marginsmentioning
confidence: 58%
“…The same pattern was found for the blocking activity toward Cav2.2 when compared to ziconotide. [22][23][24][25] However, it is worth noting that the improvement of the antinociceptive effect recorded for compound 5a compared with that previously reported for compound 10 in the tail flick test, (Figure 4), may be either related to a higher potency to the Cav2.2 and/or to better tissue penetration and pharmacokinetic. Indeed, the calcium channel blocker activity of 5a is 200 times higher than that of compound 10.…”
Section: Please Do Not Adjust Marginsmentioning
confidence: 58%
“…Description of the reaction procedures [22][23][24] and compounds characterization are reported in detail in the Supplementary Materials.…”
Section: Synthesis and Characterizationmentioning
confidence: 99%
“…Taking this in mind, we focused our attention on the functionalization of kyna via a variant of Steglich esterification with the previously prepared Boc-protected 2-aminoethanol [23] so as to obtain intermediate 2 in 60% yield after purification by column chromatography (see General Procedure) [24]. Compound 2 was deprotected with a mixture of TFA:DCM = 1:1 at r.t. for 1 h and the so obtained intermediate was coupled with Boc-N(Me)Phe-OH, following the standard procedure for coupling reaction [36].…”
Section: Chemistrymentioning
confidence: 99%
See 2 more Smart Citations